Dow Up 0.08% Nasdaq Down 0.30%

More On TRL.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Trimel Pharmaceuticals Corp. (TRL.TO)

-Toronto
0.40 Down 0.01(2.44%) Sep 19, 4:15PM EDT
Prev Close:0.41
Open:0.42
Bid:0.40
Ask:0.40
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.39 - 0.42
52wk Range:0.34 - 0.92
Volume:394,534
Avg Vol (3m):225,884
Market Cap:76.77M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.10
Quarterly EPS Est (Sep-14) :-0.02
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trimel Pharmaceuticals Corporation, a specialty pharmaceutical company, is engaged in developing medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback